In the SUBCUT-HF II trial, published Oct. 13, 2026, in the Journal of the American College of Cardiology, sending heart failure patients home early with a wearable furosemide pump added 4.0 days alive and out of hospital at 30 days.
An umbrella review of forty-five reviews, published Oct. 8, 2026, in Frontiers in Cardiovascular Medicine, found that intravenous iron for heart failure with iron deficiency most consistently reduced heart failure hospitalizations, while effects on survival remained uncertain.
A review published Oct. 26, 2026, in Circulation argues that activin A, released by fat around the heart, drives stiffness and fibrosis in a form of heart failure with pulmonary hypertension, and that sotatercept, which blocks this signal, improved heart…
A study of Medicare data from 2007 to 2022, published Oct. 1, 2026, in JAMA Network Open, found that colder days were linked to more heart failure hospitalizations in adults 65 and older, while hot days were not.